Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-16
2007-10-16
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S416000, C548S427000
Reexamination Certificate
active
10169415
ABSTRACT:
The present invention relates to novel isatin derivatives, pharmaceutical compositions comprising the isatin derivatives of the invention, methods of preparing the isatin derivatives of the invention, their use in the treatment of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons, and methods of treatment of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons.
REFERENCES:
patent: 4322533 (1982-03-01), Lesher et al.
patent: 0 432 648 (1991-06-01), None
patent: 0 529 636 (1993-03-01), None
patent: 0 089 394 (1993-08-01), None
patent: 0 556 393 (1993-08-01), None
patent: 0 572 852 (1993-12-01), None
patent: 0 919 554 (1999-06-01), None
patent: 1 002 535 (2000-05-01), None
patent: 06 228112 (1994-08-01), None
patent: 94/26747 (1994-11-01), None
patent: 96/08494 (1996-03-01), None
patent: 96/08495 (1996-03-01), None
patent: 96/11922 (1996-04-01), None
patent: 96/12724 (1996-05-01), None
patent: 98/14447 (1998-04-01), None
patent: WO98/14447 (1998-04-01), None
patent: 99/49864 (1999-10-01), None
patent: 00/01376 (2000-01-01), None
patent: 00/71102 (2000-05-01), None
patent: 00/33834 (2000-06-01), None
Derwent WPI; Accession No. 1993-068702/199309; abstract of NZ 244026.
J Pharmacol Exp Ther, vol. 289, No. 3, pp. 1492-1501 (1999) (Abstract).
Jensen et al., Neurochem. Int., vol. 32, pp. 505-513 (1998).
Ohmori et al., J. Med. Chem., vol. 39, pp. 3971-3979 (1996).
Ohmori et al., J. Med. Chem. vol. 39, pp. 1331-1338 (1996).
Winkler et al., Pharmacology and Pathophysiology, CNS Drugs, vol. 2, No. 6, pp. 466-478 (1994).
Science, vol. 264, pp. 772-774 (1994).
Pechan et al., NeuroReport, vol. 6, pp. 669-672 (1995).
Gronborg Mette
Moller Arne
Peters Dan
Birch & Stewart Kolasch & Birch, LLP
Neurosearch A/S
Ward Paul V.
Wilson James O.
LandOfFree
Isatine derivatives with neurotrophic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isatine derivatives with neurotrophic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isatine derivatives with neurotrophic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3834551